gene,annotation
ABCB1,stem cell proliferation
ABI3,defense response to tumor cell
ACE,mononuclear cell proliferation
ACKR3,angiogenesis
ACTG1,angiogenesis
ACVR2A,Sertoli cell proliferation
ACVR2B,lymphangiogenesis
ADAMTS12,cellular response to tumor necrosis factor
ADAMTS9,negative regulation of sprouting angiogenesis
ADGRA2,regulation of angiogenesis
ADGRA2,sprouting angiogenesis
ADGRB3,negative regulation of angiogenesis
ADIPOQ,negative regulation of tumor necrosis factor production
ADIPOQ,negative regulation of tumor necrosis factor-mediated signaling pathway
AFF3,response to tumor necrosis factor
AGGF1,angiogenesis
AGGF1,positive regulation of angiogenesis
AGGF1,positive regulation of endothelial cell proliferation
AGO1,negative regulation of angiogenesis
AKAP8,negative regulation of tumor necrosis factor production
AKT3,positive regulation of vascular endothelial cell proliferation
AKT3,positive regulation of angiogenesis
AKT3,positive regulation of cell migration involved in sprouting angiogenesis
AKT3,positive regulation of endothelial cell proliferation
AMOT,angiogenesis
AMOT,negative regulation of angiogenesis
AMOTL1,angiogenesis
ANG,angiogenesis
ANG,negative regulation of smooth muscle cell proliferation
ANG,positive regulation of endothelial cell proliferation
ANGPT1,regulation of skeletal muscle satellite cell proliferation
ANGPT1,sprouting angiogenesis
ANGPT1,regulation of tumor necrosis factor production
ANGPT1,angiogenesis
ANGPT1,regulation of endothelial cell proliferation
ANPEP,angiogenesis
ANXA2,angiogenesis
APLNR,angiogenesis
APLNR,positive regulation of angiogenesis
APLNR,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis
AREG,glial cell proliferation
AREG,epithelial cell proliferation involved in mammary gland duct elongation
ARHGAP5,positive regulation of mesenchymal cell proliferation
ARID2,cardiac muscle cell proliferation
ARID5B,cellular response to leukemia inhibitory factor
ARNT,positive regulation of endothelial cell proliferation
ATP5F1B,angiogenesis
AXIN2,stem cell proliferation
AXL,negative regulation of tumor necrosis factor production
AZI2,dendritic cell proliferation
B2M,negative regulation of epithelial cell proliferation
BABAM1,hematopoietic stem cell proliferation
BAP1,common myeloid progenitor cell proliferation
BBC3,execution phase of apoptosis
BCL2,B cell proliferation
BCL2L1,dendritic cell proliferation
BCL2L1,positive regulation of mononuclear cell proliferation
BCL2L2,Sertoli cell proliferation
BCL6,regulation of T cell proliferation
BCL6,positive regulation of B cell proliferation
BCL6,B cell proliferation
BCLAF1,cellular response to leukemia inhibitory factor
BIRC3,tumor necrosis factor-mediated signaling pathway
BMP5,positive regulation of epithelial cell proliferation
BMP7,metanephric mesenchymal cell proliferation involved in metanephros development
BMP7,negative regulation of glomerular mesangial cell proliferation
BMPR1A,regulation of cardiac muscle cell proliferation
BMPR1A,positive regulation of mesenchymal cell proliferation
BMPR1A,positive regulation of epithelial cell proliferation
BMPR1A,positive regulation of cardiac muscle cell proliferation
BMPR1A,epithelial cell proliferation
BMPR1A,angiogenesis
BMPR2,endothelial cell proliferation
BMPR2,negative regulation of cell proliferation involved in heart valve morphogenesis
BMPR2,negative regulation of smooth muscle cell proliferation
BMPR2,lymphangiogenesis
BOK,regulation of chorionic trophoblast cell proliferation
BOK,cellular component disassembly involved in execution phase of apoptosis
BOK,positive regulation of execution phase of apoptosis
BRCA2,negative regulation of mammary gland epithelial cell proliferation
BRCA2,inner cell mass cell proliferation
BRCA2,hematopoietic stem cell proliferation
BTG1,positive regulation of angiogenesis
BTK,positive regulation of B cell proliferation
BTK,negative regulation of B cell proliferation
BTK,positive regulation of tumor necrosis factor production
C3,positive regulation of angiogenesis
C3AR1,positive regulation of angiogenesis
CALD1,angiogenesis
CARD11,B cell proliferation
CARD11,positive regulation of B cell proliferation
CARD11,"CD4-positive, alpha-beta T cell proliferation"
CARD11,"positive regulation of CD4-positive, alpha-beta T cell proliferation"
CASP3,response to tumor necrosis factor
CASP3,negative regulation of B cell proliferation
CBLB,"negative regulation of CD4-positive, alpha-beta T cell proliferation"
CBLB,"CD4-positive, alpha-beta T cell proliferation"
CCL26,cellular response to tumor necrosis factor
CCL26,positive regulation of endothelial cell proliferation
CCN6,negative regulation of angiogenesis
CCND1,mammary gland epithelial cell proliferation
CCND1,positive regulation of mammary gland epithelial cell proliferation
CCND3,T cell proliferation
CCNE1,positive regulation of mesenchymal stem cell proliferation
CD19,B cell proliferation involved in immune response
CD1D,positive regulation of T cell proliferation
CD209,regulation of T cell proliferation
CD209,positive regulation of T cell proliferation
CD22,regulation of B cell proliferation
CD274,negative regulation of tumor necrosis factor superfamily cytokine production
CD274,regulation of activated T cell proliferation
CD274,"negative regulation of CD4-positive, alpha-beta T cell proliferation"
CD274,positive regulation of tolerance induction to tumor cell
CD274,negative regulation of T cell proliferation
CD274,negative regulation of activated T cell proliferation
CD274,positive regulation of T cell proliferation
CD276,positive regulation of T cell proliferation
CD28,"positive regulation of CD4-positive, alpha-beta T cell proliferation"
CD28,"CD4-positive, alpha-beta T cell proliferation"
CD28,positive regulation of T cell proliferation
CD36,positive regulation of tumor necrosis factor production
CD58,cellular response to tumor necrosis factor
CD70,tumor necrosis factor-mediated signaling pathway
CD70,B cell proliferation
CD70,positive regulation of T cell proliferation
CD74,positive regulation of B cell proliferation
CD86,negative regulation of T cell proliferation
CD86,positive regulation of T cell proliferation
CDC73,negative regulation of epithelial cell proliferation
CDH13,positive regulation of smooth muscle cell proliferation
CDH13,sprouting angiogenesis
CDH13,positive regulation of endothelial cell proliferation
CDK6,negative regulation of epithelial cell proliferation
CDKN2B,negative regulation of glial cell proliferation
CDKN2B,negative regulation of epithelial cell proliferation
CDKN2C,stem cell proliferation
CDKN2C,negative regulation of stem cell proliferation
CEBPA,hematopoietic stem cell proliferation
CEBPA,negative regulation of hematopoietic stem cell proliferation
CEBPA,cellular response to tumor necrosis factor
CELA1,positive regulation of angiogenesis
CHEK1,inner cell mass cell proliferation
CHRNB2,positive regulation of B cell proliferation
CITED2,negative regulation of cardiac muscle cell proliferation
CLEC4G,alpha-beta T cell proliferation
CLEC4G,negative regulation of alpha-beta T cell proliferation
CLEC4G,negative regulation of immature T cell proliferation in thymus
CLEC4G,immature T cell proliferation in thymus
COL1A1,cellular response to tumor necrosis factor
COL4A2,negative regulation of angiogenesis
COL4A2,angiogenesis
CPNE1,positive regulation of tumor necrosis factor-mediated signaling pathway
CR1,negative regulation of T cell proliferation
CREB1,cellular response to leukemia inhibitory factor
CREB3L1,negative regulation of sprouting angiogenesis
CRP,negative regulation of mononuclear cell proliferation
CRTAM,activated T cell proliferation
CRTAM,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target
CRTAM,negative regulation of activated T cell proliferation
CRTAM,detection of tumor cell
CSF1,positive regulation of mononuclear cell proliferation
CSF1,microglial cell proliferation
CSF1R,microglial cell proliferation
CSPG4,angiogenesis
CTLA4,negative regulation of T cell proliferation
CTLA4,negative regulation of B cell proliferation
CX3CR1,positive regulation of angiogenesis
CX3CR1,regulation of tumor necrosis factor production
CX3CR1,cellular response to tumor necrosis factor
CXCR2,positive regulation of angiogenesis
CYLD,regulation of tumor necrosis factor-mediated signaling pathway
CYP7B1,epithelial cell proliferation
CYP7B1,positive regulation of epithelial cell proliferation
DAB2IP,negative regulation of angiogenesis
DAB2IP,angiogenesis
DAB2IP,negative regulation of epithelial cell proliferation
DAB2IP,cellular response to tumor necrosis factor
DACH1,type B pancreatic cell proliferation
DACH1,negative regulation of cell proliferation involved in contact inhibition
DCHS1,condensed mesenchymal cell proliferation
DCSTAMP,cellular response to tumor necrosis factor
DDR2,positive regulation of hepatic stellate cell proliferation
DDR2,positive regulation of vascular associated smooth muscle cell proliferation
DGCR8,regulation of stem cell proliferation
DICER1,negative regulation of Schwann cell proliferation
DICER1,negative regulation of tumor necrosis factor-mediated signaling pathway
DICER1,negative regulation of tumor necrosis factor production
DISP3,positive regulation of neural precursor cell proliferation
DLC1,positive regulation of execution phase of apoptosis
DLEC1,defense response to tumor cell
DLL1,positive regulation of sprouting angiogenesis
DNMT1,positive regulation of vascular associated smooth muscle cell proliferation
DOCK2,alpha-beta T cell proliferation
DOCK8,memory T cell proliferation
E2F2,negative regulation of sprouting angiogenesis
E2F3,negative regulation of fat cell proliferation
EAF2,negative regulation of epithelial cell proliferation involved in prostate gland development
EAF2,epithelial cell proliferation involved in prostate gland development
EDNRB,regulation of epithelial cell proliferation
EGFL7,angiogenesis
EGFL7,positive regulation of endothelial cell proliferation
EGR1,positive regulation of glomerular metanephric mesangial cell proliferation
EGR1,glomerular mesangial cell proliferation
EGR3,cell migration involved in sprouting angiogenesis
EGR3,positive regulation of endothelial cell proliferation
EIF2AK3,angiogenesis
EIF2S2,male germ cell proliferation
EIF4A2,cellular response to leukemia inhibitory factor
EIF5A,tumor necrosis factor-mediated signaling pathway
ELF4,natural killer cell proliferation
ELF4,negative regulation of tumor necrosis factor production
ELF4,NK T cell proliferation
ELL,negative regulation of epithelial cell proliferation involved in prostate gland development
ELL,epithelial cell proliferation involved in prostate gland development
ELN,regulation of smooth muscle cell proliferation
EPAS1,angiogenesis
EPCAM,positive regulation of stem cell proliferation
EPHA1,positive regulation of angiogenesis
EPHA1,angiogenesis
EPHA2,negative regulation of lymphangiogenesis
EPHA2,mammary gland epithelial cell proliferation
EPHA2,regulation of angiogenesis
EPHA2,negative regulation of angiogenesis
EPHA2,blood vessel endothelial cell proliferation involved in sprouting angiogenesis
EPHB1,negative regulation of skeletal muscle satellite cell proliferation
EPHB1,angiogenesis
EPHB1,neural precursor cell proliferation
EPHB4,angiogenesis
EPPK1,negative regulation of epithelial cell proliferation
ERBB2,cellular response to tumor necrosis factor
ERBB4,positive regulation of cardiac muscle cell proliferation
ERBIN,cellular response to tumor necrosis factor
ERCC2,hematopoietic stem cell proliferation
ERRFI1,epithelial cell proliferation
ETS1,positive regulation of angiogenesis
ETS1,regulation of angiogenesis
ETV5,positive regulation of glial cell proliferation
ETV6,hematopoietic stem cell proliferation
EXT1,response to leukemia inhibitory factor
EYA1,positive regulation of epithelial cell proliferation
EYA1,epithelial cell proliferation
FANCA,regulation of germ cell proliferation
FAS,tumor necrosis factor-mediated signaling pathway
FAS,negative regulation of angiogenesis
FBLN1,negative regulation of stem cell proliferation
FBXW7,regulation of cell migration involved in sprouting angiogenesis
FCGR2B,negative regulation of B cell proliferation
FCGR3A,positive regulation of tumor necrosis factor production
FCGR3A,positive regulation of natural killer cell proliferation
FES,cardiac muscle cell proliferation
FGF10,positive regulation of urothelial cell proliferation
FGF10,angiogenesis
FGF10,positive regulation of epithelial cell proliferation
FGF10,urothelial cell proliferation
FGF10,endothelial cell proliferation
FGF10,positive regulation of epithelial cell proliferation involved in wound healing
FGF10,epithelial cell proliferation involved in salivary gland morphogenesis
FGF10,positive regulation of endothelial cell proliferation
FGF10,epithelial cell proliferation
FGF2,endothelial cell proliferation
FGF2,positive regulation of angiogenesis
FGF2,regulation of cell migration involved in sprouting angiogenesis
FGF2,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis
FGF2,growth factor dependent regulation of skeletal muscle satellite cell proliferation
FGF2,cell migration involved in sprouting angiogenesis
FGF2,positive regulation of endothelial cell proliferation
FGF2,regulation of angiogenesis
FGF4,positive regulation of stem cell proliferation
FGF4,mesenchymal cell proliferation
FGF4,cellular response to leukemia inhibitory factor
FGF4,stem cell proliferation
FGF6,angiogenesis
FGFBP1,positive regulation of cell migration involved in sprouting angiogenesis
FGFBP1,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis
FGFR1,angiogenesis
FGFR1,mesenchymal cell proliferation
FGFR1,positive regulation of mesenchymal cell proliferation
FGFR2,angiogenesis
FGFR2,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow
FGFR2,positive regulation of mesenchymal cell proliferation
FLCN,negative regulation of cell proliferation involved in kidney development
FLCN,epithelial cell proliferation
FLCN,negative regulation of epithelial cell proliferation
FLCN,cell proliferation involved in kidney development
FLNA,angiogenesis
FLT1,angiogenesis
FLT1,negative regulation of vascular endothelial cell proliferation
FLT1,positive regulation of angiogenesis
FLT3,common myeloid progenitor cell proliferation
FLT4,lymphangiogenesis
FLT4,positive regulation of endothelial cell proliferation
FLT4,sprouting angiogenesis
FLT4,angiogenesis
FMNL3,angiogenesis
FMR1,negative regulation of tumor necrosis factor production
FOXF1,positive regulation of mesenchymal cell proliferation
FOXO1,regulation of neural precursor cell proliferation
FOXO3,tumor necrosis factor-mediated signaling pathway
FOXO3,regulation of neural precursor cell proliferation
FOXO4,negative regulation of angiogenesis
FOXP1,cellular response to tumor necrosis factor
FOXP1,regulation of tumor necrosis factor production
FOXP1,positive regulation of smooth muscle cell proliferation
FRMD8,positive regulation of tumor necrosis factor production
FRS2,regulation of epithelial cell proliferation
FRS2,positive regulation of vascular associated smooth muscle cell proliferation
FTO,regulation of white fat cell proliferation
FXR1,negative regulation of tumor necrosis factor production
FZD3,negative regulation of execution phase of apoptosis
FZD3,cell proliferation in midbrain
GAB1,angiogenesis
GAB1,positive regulation of angiogenesis
GATA2,positive regulation of cell migration involved in sprouting angiogenesis
GATA2,positive regulation of angiogenesis
GATA2,negative regulation of neural precursor cell proliferation
GATA3,negative regulation of mammary gland epithelial cell proliferation
GATA4,positive regulation of angiogenesis
GATA6,positive regulation of cardiac muscle cell proliferation
GATA6,cardiac muscle cell proliferation
GATA6,negative regulation of sebum secreting cell proliferation
GATA6,positive regulation of angiogenesis
GDF5,negative regulation of epithelial cell proliferation
GINS1,inner cell mass cell proliferation
GLI1,positive regulation of cardiac muscle cell proliferation
GLI3,lateral ganglionic eminence cell proliferation
GNA12,negative regulation of vascular associated smooth muscle cell proliferation
GNA13,negative regulation of vascular associated smooth muscle cell proliferation
GNAI2,positive regulation of neural precursor cell proliferation
GNAI2,positive regulation of vascular associated smooth muscle cell proliferation
GPAM,positive regulation of activated T cell proliferation
GPAM,activated T cell proliferation
GPC3,cell proliferation involved in kidney development
GPC3,negative regulation of epithelial cell proliferation
GPC3,cell proliferation involved in metanephros development
GPC3,epithelial cell proliferation
GPC3,mesenchymal cell proliferation involved in ureteric bud development
GPR183,positive regulation of B cell proliferation
GPS2,negative regulation of tumor necrosis factor-mediated signaling pathway
GPX1,angiogenesis involved in wound healing
GPX1,regulation of mammary gland epithelial cell proliferation
GREM1,positive regulation of angiogenesis
GREM1,cell migration involved in sprouting angiogenesis
GSDME,positive regulation of immune response to tumor cell
GSDME,cellular response to tumor necrosis factor
GTF2I,negative regulation of angiogenesis
H2BC11,negative regulation of tumor necrosis factor-mediated signaling pathway
HDAC7,positive regulation of cell migration involved in sprouting angiogenesis
HDAC9,positive regulation of cell migration involved in sprouting angiogenesis
HES1,cellular response to tumor necrosis factor
HES1,regulation of epithelial cell proliferation
HES1,T cell proliferation
HES1,positive regulation of T cell proliferation
HES1,negative regulation of glial cell proliferation
HEY1,angiogenesis
HGF,skeletal muscle cell proliferation
HGF,epithelial cell proliferation
HHLA2,positive regulation of activated T cell proliferation
HIPK2,positive regulation of angiogenesis
HLA-A,"positive regulation of CD8-positive, alpha-beta T cell proliferation"
HLA-A,T cell mediated cytotoxicity directed against tumor cell target
HLA-DRB1,positive regulation of T cell mediated immune response to tumor cell
HLA-DRB1,negative regulation of T cell proliferation
HMGA1,oncogene-induced cell senescence
HMGA2,positive regulation of stem cell proliferation
HMGA2,positive regulation of cell proliferation in bone marrow
HMGA2,positive regulation of angiogenesis
HMGA2,oncogene-induced cell senescence
HMGB1,positive regulation of activated T cell proliferation
HMGB1,positive regulation of tumor necrosis factor production
HMGB1,regulation of T cell mediated immune response to tumor cell
HNF1B,epithelial cell proliferation
HOXA3,angiogenesis
HOXA3,positive regulation of stem cell proliferation
HOXA3,stem cell proliferation
HOXA7,angiogenesis
HOXB13,angiogenesis
HSPG2,angiogenesis
HSPG2,positive regulation of endothelial cell proliferation
HSPG2,negative regulation of angiogenesis
HTATIP2,angiogenesis
HTATIP2,regulation of angiogenesis
ICOSLG,positive regulation of activated T cell proliferation
ID1,angiogenesis
IFNGR1,positive regulation of tumor necrosis factor production
IGF1,positive regulation of trophectodermal cell proliferation
IGF1,positive regulation of epithelial cell proliferation
IGF1,positive regulation of vascular associated smooth muscle cell proliferation
IGF1,negative regulation of tumor necrosis factor production
IGF1,positive regulation of activated T cell proliferation
IGF1,positive regulation of smooth muscle cell proliferation
IGF1R,positive regulation of smooth muscle cell proliferation
IGF2,positive regulation of activated T cell proliferation
IGF2,positive regulation of vascular endothelial cell proliferation
IL10,negative regulation of B cell proliferation
IL10,positive regulation of endothelial cell proliferation
IL10,negative regulation of T cell proliferation
IL10,negative regulation of vascular associated smooth muscle cell proliferation
IL10,positive regulation of vascular associated smooth muscle cell proliferation
IL10,negative regulation of tumor necrosis factor production
IL10,positive regulation of sprouting angiogenesis
IL10,B cell proliferation
IL1A,positive regulation of tumor necrosis factor production
IL1A,positive regulation of immature T cell proliferation in thymus
IL1A,positive regulation of angiogenesis
IL1B,positive regulation of T cell proliferation
IL1B,positive regulation of immature T cell proliferation in thymus
IL1B,positive regulation of angiogenesis
IL2,activated T cell proliferation
IL2,positive regulation of B cell proliferation
IL2,"regulation of CD4-positive, alpha-beta T cell proliferation"
IL2,positive regulation of activated T cell proliferation
IL6ST,positive regulation of T cell proliferation
IL6ST,leukemia inhibitory factor signaling pathway
IL7R,B cell proliferation
INPP5D,negative regulation of B cell proliferation
IRAK4,positive regulation of smooth muscle cell proliferation
IRF1,"regulation of CD8-positive, alpha-beta T cell proliferation"
IRF6,negative regulation of stem cell proliferation
IRF6,stem cell proliferation
IRS2,positive regulation of B cell proliferation
IRS2,positive regulation of type B pancreatic cell proliferation
IRS2,type B pancreatic cell proliferation
IRS2,positive regulation of mesenchymal cell proliferation
ITCH,"CD4-positive, alpha-beta T cell proliferation"
ITCH,"negative regulation of CD4-positive, alpha-beta T cell proliferation"
ITGA4,positive regulation of vascular endothelial cell proliferation
ITGAV,angiogenesis
ITPKB,common myeloid progenitor cell proliferation
JAG1,regulation of epithelial cell proliferation
JAG1,angiogenesis
JAK1,positive regulation of sprouting angiogenesis
JARID2,cardiac muscle cell proliferation
JARID2,negative regulation of cardiac muscle cell proliferation
JARID2,cellular response to leukemia inhibitory factor
KAT7,positive regulation of hematopoietic stem cell proliferation
KDM2B,negative regulation of neural precursor cell proliferation
KDR,angiogenesis
KDR,positive regulation of endothelial cell proliferation
KDR,positive regulation of mesenchymal cell proliferation
KDR,cell migration involved in sprouting angiogenesis
KDR,mesenchymal cell proliferation
KIT,mast cell proliferation
KIT,positive regulation of T cell proliferation
KIT,positive regulation of mast cell proliferation
KIT,T cell proliferation
KIT,positive regulation of hematopoietic stem cell proliferation
KLF2,cellular response to tumor necrosis factor
KLF2,negative regulation of sprouting angiogenesis
KLF4,defense response to tumor cell
KLF4,negative regulation of smooth muscle cell proliferation
KLF4,cellular response to leukemia inhibitory factor
KLF4,negative regulation of angiogenesis
KLF4,negative regulation of cell migration involved in sprouting angiogenesis
KLF4,positive regulation of sprouting angiogenesis
KLF5,cellular response to leukemia inhibitory factor
KLF5,angiogenesis
KLK3,negative regulation of angiogenesis
KRAS,glial cell proliferation
KRAS,positive regulation of glial cell proliferation
LAMB1,positive regulation of epithelial cell proliferation
LAMC1,positive regulation of epithelial cell proliferation
LBP,positive regulation of tumor necrosis factor production
LBP,negative regulation of tumor necrosis factor production
LEF1,sprouting angiogenesis
LEF1,B cell proliferation
LEPR,glial cell proliferation
LEPR,angiogenesis
LGR5,epithelial cell proliferation involved in renal tubule morphogenesis
LIFR,leukemia inhibitory factor signaling pathway
LILRB1,negative regulation of T cell proliferation
LILRB1,negative regulation of tumor necrosis factor production
LILRB1,T cell proliferation involved in immune response
LILRB1,negative regulation of mononuclear cell proliferation
LILRB2,positive regulation of T cell proliferation
LILRB2,negative regulation of T cell proliferation
LRP5,positive regulation of mesenchymal cell proliferation
LRRC32,negative regulation of activated T cell proliferation
LRRK2,cellular response to tumor necrosis factor
LUC7L2,regulation of type B pancreatic cell proliferation
MALT1,T cell proliferation
MAP2K1,type B pancreatic cell proliferation
MAP2K1,epithelial cell proliferation involved in lung morphogenesis
MAP2K2,epithelial cell proliferation involved in lung morphogenesis
MAP2K7,response to tumor necrosis factor
MAP4K3,response to tumor necrosis factor
MAPK7,regulation of angiogenesis
MAPK8IP1,"regulation of CD8-positive, alpha-beta T cell proliferation"
MC1R,negative regulation of tumor necrosis factor production
MECOM,hematopoietic stem cell proliferation
MED1,angiogenesis
MEF2C,positive regulation of cardiac muscle cell proliferation
MEF2C,positive regulation of B cell proliferation
MEF2C,B cell proliferation
MEF2D,positive regulation of vascular associated smooth muscle cell proliferation
MINAR1,negative regulation of angiogenesis
MINAR1,angiogenesis
MNAT1,positive regulation of smooth muscle cell proliferation
MRAS,cellular response to leukemia inhibitory factor
MS4A1,B cell proliferation
MSN,T cell proliferation
MYB,positive regulation of smooth muscle cell proliferation
MYB,positive regulation of glial cell proliferation
MYB,skeletal muscle cell proliferation
MYB,positive regulation of hepatic stellate cell proliferation
MYBL2,cellular response to leukemia inhibitory factor
MYH9,angiogenesis
MYOCD,negative regulation of vascular associated smooth muscle cell proliferation
MYOD1,cellular response to tumor necrosis factor
NAP1L1,positive regulation of neural precursor cell proliferation
NCAPG2,inner cell mass cell proliferation
NCSTN,epithelial cell proliferation
NCSTN,T cell proliferation
NDEL1,inner cell mass cell proliferation
NEFH,cellular response to leukemia inhibitory factor
NES,stem cell proliferation
NES,positive regulation of neural precursor cell proliferation
NF1,regulation of angiogenesis
NF1,endothelial cell proliferation
NF1,positive regulation of endothelial cell proliferation
NF1,Schwann cell proliferation
NF1,negative regulation of angiogenesis
NF1,angiogenesis
NF1,negative regulation of endothelial cell proliferation
NF1,mast cell proliferation
NF1,negative regulation of Schwann cell proliferation
NF2,Schwann cell proliferation
NF2,regulation of stem cell proliferation
NF2,negative regulation of Schwann cell proliferation
NF2,regulation of neural precursor cell proliferation
NFATC2,positive regulation of B cell proliferation
NFATC4,positive regulation of tumor necrosis factor production
NFIB,negative regulation of epithelial cell proliferation involved in lung morphogenesis
NFIB,stem cell proliferation
NFIB,negative regulation of stem cell proliferation
NFIB,cell proliferation in forebrain
NFIB,negative regulation of mesenchymal cell proliferation involved in lung development
NFIB,glial cell proliferation
NFKBIZ,B cell proliferation
NFKBIZ,execution phase of apoptosis
NKX3-1,cellular response to tumor necrosis factor
NKX3-1,negative regulation of epithelial cell proliferation
NKX3-1,epithelial cell proliferation involved in salivary gland morphogenesis
NKX3-1,negative regulation of epithelial cell proliferation involved in prostate gland development
NKX3-1,epithelial cell proliferation involved in prostate gland development
NOD1,positive regulation of tumor necrosis factor production
NOTCH1,negative regulation of cell proliferation involved in heart valve morphogenesis
NOTCH1,sprouting angiogenesis
NOTCH2,cellular response to tumor cell
NOTCH3,positive regulation of smooth muscle cell proliferation
NPNT,cellular response to tumor necrosis factor
NPR3,angiogenesis
NR1H4,negative regulation of tumor necrosis factor production
NR1H4,negative regulation of tumor necrosis factor-mediated signaling pathway
NR4A3,positive regulation of epithelial cell proliferation
NR4A3,common myeloid progenitor cell proliferation
NR4A3,regulation of smooth muscle cell proliferation
NR4A3,positive regulation of smooth muscle cell proliferation
NR4A3,positive regulation of vascular associated smooth muscle cell proliferation
NR4A3,regulation of type B pancreatic cell proliferation
NRAS,positive regulation of endothelial cell proliferation
NRP1,positive regulation of cell migration involved in sprouting angiogenesis
NRP1,positive regulation of endothelial cell proliferation
NRP1,angiogenesis
NRP1,cell migration involved in sprouting angiogenesis
NRP1,positive regulation of angiogenesis
NRP1,angiogenesis involved in coronary vascular morphogenesis
NRP1,sprouting angiogenesis
ODAM,positive regulation of epithelial cell proliferation involved in wound healing
OSR2,stem cell proliferation
OSR2,positive regulation of stem cell proliferation
OSR2,positive regulation of epithelial cell proliferation
PALB2,inner cell mass cell proliferation
PAX2,positive regulation of epithelial cell proliferation
PBX1,positive regulation of stem cell proliferation
PBX1,stem cell proliferation
PDCD1LG2,negative regulation of T cell proliferation
PDCD1LG2,negative regulation of activated T cell proliferation
PDCD1LG2,positive regulation of T cell proliferation
PDCD2,positive regulation of hematopoietic stem cell proliferation
PDCD6,angiogenesis
PDCD6,positive regulation of endothelial cell proliferation
PDCD6,positive regulation of angiogenesis
PDGFB,positive regulation of smooth muscle cell proliferation
PDGFB,positive regulation of endothelial cell proliferation
PDGFRA,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway
PDGFRB,angiogenesis
PDPK1,positive regulation of vascular endothelial cell proliferation
PDPK1,positive regulation of sprouting angiogenesis
PDPK1,positive regulation of angiogenesis
PELI3,negative regulation of tumor necrosis factor-mediated signaling pathway
PEX2,negative regulation of epithelial cell proliferation
PFKP,cellular response to leukemia inhibitory factor
PGR,regulation of epithelial cell proliferation
PHOX2B,type B pancreatic cell proliferation
PHOX2B,negative regulation of type B pancreatic cell proliferation
PIGA,cellular response to leukemia inhibitory factor
PIK3C2A,positive regulation of cell migration involved in sprouting angiogenesis
PIK3CA,positive regulation of smooth muscle cell proliferation
PIK3CA,angiogenesis
PIK3CB,angiogenesis involved in wound healing
PIK3CB,endothelial cell proliferation
PIK3CB,negative regulation of sprouting angiogenesis
PIK3CD,positive regulation of endothelial cell proliferation
PIK3CD,positive regulation of angiogenesis
PIK3CG,regulation of angiogenesis
PIK3CG,angiogenesis
PIK3CG,T cell proliferation
PIK3R3,cell migration involved in sprouting angiogenesis
PIK3R6,angiogenesis
PIK3R6,positive regulation of angiogenesis
PIM1,positive regulation of cardiac muscle cell proliferation
PIM1,regulation of hematopoietic stem cell proliferation
PKHD1,positive regulation of epithelial cell proliferation
PLAG1,positive regulation of glial cell proliferation
PLCG1,positive regulation of angiogenesis
PLCG2,positive regulation of tumor necrosis factor production
PLK2,positive regulation of cell migration involved in sprouting angiogenesis
PLK2,negative regulation of angiogenesis
PLXDC1,angiogenesis
PLXND1,regulation of angiogenesis
PLXND1,angiogenesis
PML,negative regulation of angiogenesis
PPARD,negative regulation of epithelial cell proliferation
PPARD,positive regulation of fat cell proliferation
PPARD,fat cell proliferation
PPARD,regulation of skeletal muscle satellite cell proliferation
PPARG,negative regulation of smooth muscle cell proliferation
PPP3CA,positive regulation of activated T cell proliferation
PPP3CA,regulation of cell proliferation involved in kidney morphogenesis
PRDM1,sebum secreting cell proliferation
PRF1,immune response to tumor cell
PRF1,defense response to tumor cell
PRKAR1A,negative regulation of activated T cell proliferation
PRKAR1A,cardiac muscle cell proliferation
PRKCB,positive regulation of angiogenesis
PRKCI,positive regulation of glial cell proliferation
PRKCQ,"positive regulation of CD4-positive, alpha-beta T cell proliferation"
PRKCQ,"CD4-positive, alpha-beta T cell proliferation"
PRKD2,angiogenesis
PRKD2,positive regulation of angiogenesis
PRKD2,positive regulation of endothelial cell proliferation
PRKDC,regulation of smooth muscle cell proliferation
PRKG1,negative regulation of vascular associated smooth muscle cell proliferation
PRKX,angiogenesis
PRKX,endothelial cell proliferation
PRLR,positive regulation of B cell proliferation
PRPF8,cellular response to tumor necrosis factor
PRRX1,positive regulation of mesenchymal cell proliferation
PRRX1,positive regulation of stem cell proliferation
PRRX1,stem cell proliferation
PRRX1,mesenchymal cell proliferation
PTCH1,stem cell proliferation
PTCH1,cell proliferation involved in metanephros development
PTCH1,negative regulation of stem cell proliferation
PTGDR2,negative regulation of male germ cell proliferation
PTK2,angiogenesis
PTK2B,tumor necrosis factor-mediated signaling pathway
PTK2B,sprouting angiogenesis
PTK2B,positive regulation of angiogenesis
PTK2B,glial cell proliferation
PTPN14,lymphangiogenesis
PTPN2,negative regulation of tumor necrosis factor-mediated signaling pathway
PTPN22,regulation of natural killer cell proliferation
PTPN22,negative regulation of tumor necrosis factor production
PTPN22,"positive regulation of CD8-positive, alpha-beta T cell proliferation"
PTPN6,negative regulation of tumor necrosis factor production
PTPRB,angiogenesis
PTPRC,positive regulation of tumor necrosis factor production
PTPRC,positive regulation of B cell proliferation
PTPRC,B cell proliferation
PTPRC,alpha-beta T cell proliferation
PTPRC,positive regulation of alpha-beta T cell proliferation
PTPRC,positive regulation of T cell proliferation
RAC2,positive regulation of mast cell proliferation
RAC2,mast cell proliferation
RAC2,regulation of T cell proliferation
RAD21,negative regulation of tumor necrosis factor production
RAPGEF3,angiogenesis
RAPGEF3,positive regulation of angiogenesis
RAPGEF3,regulation of angiogenesis
RARA,negative regulation of tumor necrosis factor production
RBM10,negative regulation of vascular associated smooth muscle cell proliferation
RBM10,vascular associated smooth muscle cell proliferation
RBPJ,stem cell proliferation
RBPJ,positive regulation of cardiac muscle cell proliferation
RBPJ,epithelial cell proliferation
RBPJ,positive regulation of epithelial cell proliferation
RBPJ,angiogenesis
RET,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis
RGCC,negative regulation of angiogenesis
RGCC,negative regulation of endothelial cell proliferation
RHOA,negative regulation of cell migration involved in sprouting angiogenesis
RHOB,angiogenesis
RHOB,positive regulation of angiogenesis
RICTOR,positive regulation of endothelial cell proliferation
RNF213,angiogenesis
RNF213,sprouting angiogenesis
RNF43,stem cell proliferation
ROBO1,negative regulation of mammary gland epithelial cell proliferation
ROBO1,cell migration involved in sprouting angiogenesis
RPGR,neural precursor cell proliferation
RPGRIP1,neural precursor cell proliferation
RPTOR,positive regulation of endothelial cell proliferation
RRAS,positive regulation of angiogenesis
RREB1,positive regulation of mammary gland epithelial cell proliferation
RSPO3,sprouting angiogenesis
RUNX1,positive regulation of angiogenesis
RUNX1,regulation of cardiac muscle cell proliferation
RUNX1,hematopoietic stem cell proliferation
RUNX2,positive regulation of epithelial cell proliferation
RUNX2,positive regulation of stem cell proliferation
RUNX2,stem cell proliferation
RUNX2,epithelial cell proliferation
S100A1,positive regulation of sprouting angiogenesis
S100A7,angiogenesis
S1PR1,angiogenesis
S1PR1,positive regulation of smooth muscle cell proliferation
SALL4,inner cell mass cell proliferation
SAV1,negative regulation of cardiac muscle cell proliferation
SAV1,cardiac muscle cell proliferation
SAV1,negative regulation of epithelial cell proliferation
SAV1,epithelial cell proliferation
SCN5A,positive regulation of epithelial cell proliferation
SDC4,negative regulation of T cell proliferation
SEMA3E,negative regulation of angiogenesis
SEMA3E,sprouting angiogenesis
SEMA5A,positive regulation of angiogenesis
SEMA5A,positive regulation of endothelial cell proliferation
SEMA5A,blood vessel endothelial cell proliferation involved in sprouting angiogenesis
SEMA6A,negative regulation of angiogenesis
SEMA6A,negative regulation of cell adhesion involved in sprouting angiogenesis
SEMA6A,negative regulation of sprouting angiogenesis
SERPINB7,positive regulation of glomerular mesangial cell proliferation
SETD2,angiogenesis
SETD4,positive regulation of tumor necrosis factor production
SETD4,regulation of cell proliferation in bone marrow
SF1,negative regulation of smooth muscle cell proliferation
SFRP1,positive regulation of epithelial cell proliferation
SFRP1,negative regulation of epithelial cell proliferation
SFRP1,regulation of angiogenesis
SFRP2,positive regulation of angiogenesis
SFRP2,hematopoietic stem cell proliferation
SFRP2,negative regulation of epithelial cell proliferation
SHH,T cell proliferation
SHH,positive regulation of skeletal muscle cell proliferation
SHH,negative regulation of T cell proliferation
SHH,skeletal muscle cell proliferation
SHH,positive regulation of immature T cell proliferation in thymus
SHOC2,negative regulation of neural precursor cell proliferation
SIRPA,negative regulation of tumor necrosis factor production
SIRPA,regulation of tumor necrosis factor production
SIX1,mesenchymal cell proliferation involved in ureter development
SIX1,regulation of epithelial cell proliferation
SIX1,regulation of skeletal muscle satellite cell proliferation
SIX1,regulation of skeletal muscle cell proliferation
SIX1,positive regulation of mesenchymal cell proliferation involved in ureter development
SIX2,mesenchymal stem cell proliferation
SIX2,condensed mesenchymal cell proliferation
SKI,cardiac muscle cell proliferation
SKI,negative regulation of Schwann cell proliferation
SLAMF1,positive regulation of activated T cell proliferation
SLAMF1,negative regulation of tumor necrosis factor production
SLAMF1,natural killer cell proliferation
SLC12A6,angiogenesis
SLC39A12,positive regulation of sprouting angiogenesis
SLC4A2,"negative regulation of CD8-positive, alpha-beta T cell proliferation"
SLIT2,cell migration involved in sprouting angiogenesis
SMO,positive regulation of epithelial cell proliferation
SMO,positive regulation of mesenchymal cell proliferation
SMO,epithelial cell proliferation
SOCS3,cellular response to leukemia inhibitory factor
SOS1,regulation of T cell proliferation
SOX10,negative regulation of Schwann cell proliferation
SOX11,negative regulation of glial cell proliferation
SOX11,positive regulation of stem cell proliferation
SOX11,glial cell proliferation
SOX11,positive regulation of lens epithelial cell proliferation
SOX17,regulation of stem cell proliferation
SOX17,angiogenesis
SOX17,cellular response to leukemia inhibitory factor
SOX2,negative regulation of epithelial cell proliferation
SPHK1,positive regulation of angiogenesis
SPHK1,regulation of tumor necrosis factor-mediated signaling pathway
SPHK1,response to tumor necrosis factor
SPI1,defense response to tumor cell
SPI1,oncogene-induced cell senescence
SPN,positive regulation of tumor necrosis factor production
SPN,positive regulation of T cell proliferation
SPN,T cell proliferation
SPN,negative regulation of T cell proliferation
SPTA1,positive regulation of T cell proliferation
SRPX,negative regulation of cell proliferation involved in contact inhibition
SRSF3,cellular response to leukemia inhibitory factor
ST6GAL1,positive regulation of mononuclear cell proliferation
STAB1,negative regulation of angiogenesis
STAT1,positive regulation of mesenchymal cell proliferation
STAT1,negative regulation of endothelial cell proliferation
STAT5A,positive regulation of endothelial cell proliferation
STAT5B,natural killer cell proliferation
STAT5B,positive regulation of natural killer cell proliferation
STAT5B,positive regulation of activated T cell proliferation
STAT5B,activated T cell proliferation
STAT6,regulation of mast cell proliferation
STAT6,mammary gland epithelial cell proliferation
STIM1,positive regulation of angiogenesis
SULF1,negative regulation of angiogenesis
SULF1,negative regulation of endothelial cell proliferation
SYK,angiogenesis
TAL1,angiogenesis
TBX3,positive regulation of stem cell proliferation
TBX3,negative regulation of cell proliferation involved in heart morphogenesis
TBX3,stem cell proliferation
TCF7L2,regulation of smooth muscle cell proliferation
TCF7L2,positive regulation of epithelial cell proliferation
TCL1A,cellular response to tumor necrosis factor
TEX14,cellular response to leukemia inhibitory factor
TFDP1,negative regulation of fat cell proliferation
TFRC,positive regulation of B cell proliferation
TFRC,positive regulation of T cell proliferation
TFRC,cellular response to leukemia inhibitory factor
TGFA,positive regulation of epithelial cell proliferation
TGFA,angiogenesis
TGFBR1,positive regulation of endothelial cell proliferation
TGFBR1,negative regulation of endothelial cell proliferation
TGFBR1,endothelial cell proliferation
TGFBR2,cell proliferation involved in endocardial cushion morphogenesis
TGFBR3,cardiac muscle cell proliferation
TGFBR3,positive regulation of cardiac muscle cell proliferation
TGFBR3,negative regulation of epithelial cell proliferation
TGFBR3,positive regulation of cell migration involved in sprouting angiogenesis
THBS1,positive regulation of smooth muscle cell proliferation
THBS1,positive regulation of angiogenesis
THBS1,negative regulation of angiogenesis
THBS1,positive regulation of tumor necrosis factor production
THBS1,negative regulation of endothelial cell proliferation
THBS1,sprouting angiogenesis
THBS2,negative regulation of angiogenesis
THSD7A,angiogenesis
TIAL1,positive regulation of stem cell proliferation
TIAL1,stem cell proliferation
TJP1,positive regulation of sprouting angiogenesis
TLE4,cellular response to leukemia inhibitory factor
TLR2,positive regulation of tumor necrosis factor production
TLR4,positive regulation of B cell proliferation
TLR4,positive regulation of tumor necrosis factor production
TLR4,B cell proliferation involved in immune response
TLR4,negative regulation of tumor necrosis factor production
TLR9,positive regulation of B cell proliferation
TLR9,positive regulation of tumor necrosis factor production
TMSB4X,tumor necrosis factor-mediated signaling pathway
TNFAIP3,regulation of tumor necrosis factor-mediated signaling pathway
TNFAIP3,negative regulation of tumor necrosis factor production
TNFAIP3,negative regulation of smooth muscle cell proliferation
TNFRSF11A,tumor necrosis factor-mediated signaling pathway
TNFRSF11A,response to tumor necrosis factor
TNFRSF14,negative regulation of alpha-beta T cell proliferation
TNFRSF14,tumor necrosis factor-mediated signaling pathway
TNFRSF17,tumor necrosis factor-mediated signaling pathway
TNFRSF1B,tumor necrosis factor-mediated signaling pathway
TNFRSF1B,regulation of T cell proliferation
TNFRSF8,positive regulation of tumor necrosis factor production
TNFSF13,positive regulation of endothelial cell proliferation
TNFSF13,positive regulation of angiogenesis
TNFSF13,angiogenesis
TNFSF8,regulation of T cell proliferation
TNN,positive regulation of sprouting angiogenesis
TOX,positive regulation of neural precursor cell proliferation
TP53BP2,positive regulation of execution phase of apoptosis
TP63,positive regulation of stem cell proliferation
TP63,stem cell proliferation
TP63,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development
TP73,negative regulation of cardiac muscle cell proliferation
TRAF2,positive regulation of tumor necrosis factor-mediated signaling pathway
TRAF2,tumor necrosis factor-mediated signaling pathway
TRAF3,tumor necrosis factor-mediated signaling pathway
TRAF5,tumor necrosis factor-mediated signaling pathway
TRAIP,negative regulation of tumor necrosis factor-mediated signaling pathway
TRIM24,epithelial cell proliferation
TRIM24,negative regulation of epithelial cell proliferation
TSC22D1,negative regulation of hematopoietic stem cell proliferation
TSPAN18,regulation of sprouting angiogenesis
TWIST1,positive regulation of epithelial cell proliferation
TWIST1,positive regulation of angiogenesis
TWIST1,positive regulation of tumor necrosis factor production
TWIST1,negative regulation of tumor necrosis factor production
TWIST1,cell proliferation involved in heart valve development
TXNIP,cellular response to tumor cell
TYK2,positive regulation of NK T cell proliferation
TYK2,positive regulation of T cell proliferation
TYK2,positive regulation of natural killer cell proliferation
UNCX,common myeloid progenitor cell proliferation
VAV2,angiogenesis
VEGFA,cell migration involved in sprouting angiogenesis
VEGFA,positive regulation of endothelial cell proliferation
VEGFA,angiogenesis
VEGFA,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis
VEZF1,angiogenesis
WNK1,positive regulation of angiogenesis
WNT2,cell proliferation in midbrain
WNT2,positive regulation of mesenchymal cell proliferation
WNT2,epithelial cell proliferation involved in lung morphogenesis
WNT2,positive regulation of cardiac muscle cell proliferation
WNT2,cardiac muscle cell proliferation
WNT2,mesenchymal cell proliferation
WNT2,positive regulation of epithelial cell proliferation involved in lung morphogenesis
WT1,negative regulation of B cell proliferation
WT1,negative regulation of metanephric glomerular mesangial cell proliferation
WT1,negative regulation of T cell proliferation
XBP1,positive regulation of angiogenesis
XBP1,angiogenesis
XCL2,cellular response to tumor necrosis factor
XDH,negative regulation of endothelial cell proliferation
XRCC5,regulation of smooth muscle cell proliferation
YAP1,regulation of stem cell proliferation
YBX3,cellular response to tumor necrosis factor
YES1,regulation of stem cell proliferation
YTHDF2,hematopoietic stem cell proliferation
ZBTB7B,negative regulation of NK T cell proliferation
ZC3H12A,positive regulation of execution phase of apoptosis
ZC3H12A,angiogenesis
ZC3H12A,cellular response to tumor necrosis factor
ZC3H12A,positive regulation of angiogenesis
ZC3H12A,negative regulation of tumor necrosis factor production
ZEB1,regulation of mesenchymal cell proliferation
ZFP36L1,regulation of stem cell proliferation
ZFP36L1,cellular response to tumor necrosis factor
ZFP36L2,cellular response to tumor necrosis factor
ZFPM2,positive regulation of cardiac muscle cell proliferation
ZNF143,positive regulation of smooth muscle cell proliferation
ZNF503,neural precursor cell proliferation
ZNF703,positive regulation of mammary gland epithelial cell proliferation